Monday, April 24, 2006

BioWorld Top 25 Biotechnology Drugs Report

BioWorld Top 25 Biotechnology Drugs Report

Report

"The multi-billion dollar biotechnology drug market has emerged from the shadow of the pharmaceutical industry and merits critical analysis of its leading products. This new report from BioWorld Today profiles and examines the drugs driving this market and attracting
investor attention."

The BioWorld Top 25 Biotechnology Drugs Report is the first report of its kind: It delivers a comprehensive and in-depth analysis of the top 25 biotech drugs, as ranked by revenue, in one single report, and provides you with the knowledge you need to take quick action on vital business decisions related to the biotech drug market.

An attempt to research this information can lead you in many different directions, but with the BioWorld Top 25 Biotechnology Drugs Report, you can access extensive profiles of each of the top 25 leading products. Analysis includes:


Rank
Indications
Disease description & statistics
Chronology of development through approval
Patent protection dates
Competing drugs on the market and in development
Secondary indications in development
Partnerships involved in the drug
Projection of the drug's short-term future

0 Comments:

Post a Comment

Links to this post:

Create a Link

<< Home